Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases

Abstract

Neurodegenerative diseases are the result of progressive loss of neurons and axons in the central nervous system (CNS), which can lead to cognition and motor dysfunction. It is well known that CNS inflammation and immune activation play a major role in the pathophysiology of neurodegenerative diseases. Although the blood-brain barrier (BBB) is able to protect the CNS from immune activation, it becomes more permeable during inflammation, which renders the brain vulnerable to infections. A better understanding of the interaction between inflammatory mediators, such as cytokines, and the activated immune response, including astrocytes and microglia, is critical for the development of new therapeutic strategies for neurodegenerative diseases. This review first describes the role of innate immune activation in neurodegenerative diseases and illustrates the factors that contribute to the communication between the CNS and the immune system. A closer look is given at the role of the BBB in inflammation and immunity, as well as at the animal models used to study inflammation in neurodegenerative diseases. Finally, this review outlines the key pathways and biological mechanisms involved in CNS diseases, with a particular focus on multiple sclerosis (MS), Parkinson's disease (PD), and Alzheimer's disease (AD).

Methylmercury induces the expression of TNF-α selectively in the brain of mice

“…However, there are cases in which they have instead been shown to be the cause of damage to neurons. In recent years, glial contributions have been noted in the progression and exacerbation of neurodegenerative disorders including Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease891011.…”

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

“…Growing evidence indicates that unspecific neuroinflammation contributes to the pathophysiology of several neurodegenerative diseases including AD and related dementias [17,20,44]. Neuropathological findings suggest that cerebral inflammation plays a key role in the toxicity of amyloid and thus is part of an essential mechanism that determines which patients with intracerebral tau and amyloid pathology will become demented or stay nondemented.…”

Neuroprotective effects of geniposide on Alzheimer’s disease pathology

“…Although the etiologic mechanisms of AD are poorly understood, more recently, an analysis of human brain AD samples has shown highly expressed inflammatory cytokines and an up-regulation in inflammatory genes during the early stages of AD (Hollingworth et al, 2011;Sudduth et al, 2013). During neurodegenerative disease development, microglia and other cell types, including cytokines, are activated in response to misfolded proteins in the brain, also participate in the active immune defense, and are particularly important in regulating tissue homeostasis and in preserving the structural and functional characteristics of the brain (Heneka et al, 2014;Fakhoury, 2015). McGeer et al (1988) demonstrated the activation of microglial cells and astroglial cells in close proximity to the damaged or dying neurons.…”